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ARTICLE
USP48 restrains resection by site-speciﬁc cleavage
of the BRCA1 ubiquitin mark from H2A
Michael Uckelmann1, Ruth M. Densham2, Roy Baas1, Herrie H.K. Winterwerp1, Alexander Fish1,
Titia K. Sixma1 & Joanna R. Morris2
BRCA1-BARD1-catalyzed ubiquitination of histone H2A is an important regulator of the DNA
damage response, priming chromatin for repair by homologous recombination. However, no
speciﬁc deubiquitinating enzymes (DUBs) are known to antagonize this function. Here we
identify ubiquitin speciﬁc protease-48 (USP48) as a H2A DUB, speciﬁc for the C-terminal
BRCA1 ubiquitination site. Detailed biochemical analysis shows that an auxiliary ubiquitin, an
additional ubiquitin that itself does not get cleaved, modulates USP48 activity, which has
possible implications for its regulation in vivo. In cells we reveal that USP48 antagonizes
BRCA1 E3 ligase function and in BRCA1-proﬁcient cells loss of USP48 results in positioning
53BP1 further from the break site and in extended resection lengths. USP48 repression
confers a survival beneﬁt to cells treated with camptothecin and its activity acts to restrain
gene conversion and mutagenic single-strand annealing. We propose that USP48 promotes
genome stability by antagonizing BRCA1 E3 ligase function.
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To assure genomic integrity and protect against disease suchas cancer, DNA double-strand breaks (DSB) need to befaithfully repaired. The cell can employ two major path-
ways to repair DSB, homologous recombination (HR), commonly
thought of as error free, and the more error-prone non-homo-
logous end joining (NHEJ). The choice between these two path-
ways is made at the point of DNA end resection1. Minimal
processing directs repair to NHEJ whereas 5′-end resection in late
S-phase and G2 directs repair to HR mechanisms including gene
conversion (GC), which is the most accurate, and thus least
mutagenic, form of DSB repair (reviewed in refs 2,3). However,
extensive resection can result in the use of a sub-pathway of HR
repair known as single-strand annealing (SSA). In this process,
extended resection reveals direct repeat sequences around the
DNA breaks that can be annealed and the resulting single-
stranded DNA (ssDNA) ‘ﬂaps’ are processed to delete the
material between the repeats (reviewed in refs 3–5). SSA and GC
compete for the repair of DSBs in budding yeast6, but as SSA
requires extended resection to expose direct repeats, limiting
DNA end processing is critical to promoting accurate DSB repair.
How the degree of end resection is controlled is not well
understood.
Resection takes place over several deﬁned phases. It begins by
the endo- and then exonuclease activity of MRE11-CtIP, and is
extended by Exo1 and BLM-DNA2 helicase/endonuclease com-
plexes. The extensive ssDNA is bound by replication protein A
(RPA), which is either exchanged for the recombinase RAD51,
required for homology searching, strand invasion, and GC, or the
RPA-bound sequences are annealed by RAD52 if homologous
sequences are present in the resected ends3–5.
BRCA1, the breast and ovarian cancer predisposition gene
product, and 53BP1, the p53-binding protein, are opposing reg-
ulators to the degree of DNA end resection. In the absence of
BRCA1, resection is blocked by 53BP1 and its effector proteins,
promoting NHEJ and suppressing HR repair (reviewed in
refs 7,8). BRCA1 overcomes the 53BP1-mediated block through
interaction with the resection protein CtIP9 and through its E3
ubiquitin ligase activity10. The N termini of BRCA1 and BARD1
associate and establish an active E3 ubiquitin ligase11.
The role of the ligase activity in BRCA1 function has been
controversial. Although studies on the catalytically inactive
Brca1-I26A mutant in murine cells suggest no effect on DNA
repair12,13, studies on RING-less Brca1 variants and on mice
bearing a disruptive zinc-ligating variant of the Brca1 RING or
entirely deleted Brca1 imply that ligase function may be relevant
to genomic instability14–17. Moreover, the lethality of a Brca1
RING-less mouse strain is rescued by 53bp1 loss further sup-
porting a possible interaction between ligase function and
53bp116.
Recently, a target of BRCA1 E3 ligase activity has been iden-
tiﬁed as a speciﬁc group of C-terminal lysines on H2A (K125/127/
129)18, thereby establishing a third speciﬁc ubiquitination site on
H2A besides the previously identiﬁed sites K13/15 and K118/119,
targets of RNF168 and polycomb repressor complexes 1 (PRC1),
respectively19–22. Ubiquitination of H2A controls several aspects
of the damage response: modiﬁcation of K118/119 by PRC1 is
thought to mediate DNA-damage-induced local transcriptional
repression23 as well to as potentiate the downstream signaling24
resulting in 53BP1 accumulation, whereas ubiquitin conjugated at
K13/15 directly acts to promote 53BP1 interaction at damaged
chromatin25. Ubiquitination of H2A by BRCA1 promotes long-
range resection and HR repair through the recruitment and
activity of the Swr1-like remodeler, SMARCAD1, which reposi-
tions the 53BP1 block and permits resection10.
Deubiquitinating enzymes (DUBs) are able to counteract ubi-
quitination by cleavage of the isopeptide bond between
ubiquitin’s C terminus and the target protein lysine. Several
DUBs have been suggested to target H2A26–30, but very little is
known about their site speciﬁcity nor their role in the different
repair pathways. We wanted to investigate whether DUBs that act
on H2A-ubiquitin substrates show site speciﬁcity and whether
known H2A DUBs would counteract the BRCA1-induced DNA
damage response.
To ﬁnd DUBs antagonizing BRCA1 E3 ligase activity, we tested
a panel for site-speciﬁc H2A deubiquitination. In this analysis,
USP48, previously identiﬁed as an interactor of ubiquitinated
nucleosomes31 but otherwise poorly characterized, appeared
speciﬁc for the BRCA1 site and intriguingly needs an addition
ubiquitin, which itself is not cleaved in Cis on the nucleosome, to
be fully active. We show that in cells USP48 counteracts BRCA1
E3 ligase activity, restricting DNA end resection and RAD51
recruitment. Depletion of USP48 increases SSA and confers a
RAD52-dependent survival beneﬁt to cells treated with camp-
tothecin. We propose USP48 as a regulator of the DNA damage
response, counteracting BRCA1 E3 ligase activity. Moreover, we
provide evidence that USP48 acts to prevent extensive resection
and restrict the use of SSA.
Results
Assessing site speciﬁcity of H2A DUBs. Each of the E3 ligases
that modify H2A speciﬁcally monoubiquitinates distinct groups
of lysines. K125/127/129 are ubiquitinated by BRCA1-BARD1
(H2ABRCA1ub), K118/119 by PRC1 complexes (H2APRC1ub), and
K13/15 by RNF168 (H2A168ub). This site speciﬁcity is retained
in vitro18,21,22 and allows reconstitution of ubiquitinated
nucleosomes. To address whether DUBs speciﬁc for these three
sites exist, we selected a subset, previously suggested to deubi-
quitinate H2A (USP3, USP16, BAP1/ASXL126–30) and/or
involved in the DNA damage response (USP1/UAF1, USP11,
USP7,USP15, USP12/UAF1)32. In addition, we included USP48,
because it has been identiﬁed as a potent binder of ubiquitinated
nucleosomes31.
We produced the DUBs recombinantly and puriﬁed them
for biochemical characterization (Supplementary Fig. 1a, b).
To assess basal activity we examined the minimal substrate
ubiquitin–rhodamine (UbRho), where we followed increase
of ﬂuorescence intensity upon cleavage of a quenched
Rhodamine-labeled peptide. Full kinetic analysis showed that all
DUBs are active (Supplementary Fig. 1a and Supplementary
Table 1).
We then tested for site-speciﬁc cleavage of ubiquitinated
nucleosome core particles (NCPs) where a drop in
the ﬂuorescence polarization (FP) signal of TAMRA-labeled
ubiquitin (TAMRAUb) indicates cleavage (Fig. 1a). In this assay,
most DUBs have no clear preference for any of the three different
nucleosome ubiquitination sites (Supplementary Fig. 1c and d).
The exception was USP48, which has a preference for
H2ABRCA1ub over H2A168ub and H2APRC1ub. USP48 was also
the most active of the DUBs tested on a nucleosomal substrate,
where we needed to lower the DUB concentration 10-fold (to 50
nM), to allow adequate readout in the FP assay. Furthermore,
when we assessed whether a nucleosomal substrate is preferred
over the minimal substrate, by normalizing the observed rates
from the FP assay to the activity of the respective DUBs on
minimal substrate (Supplementary Fig. 1e and Fig. 1b), we found
USP3 and USP48 prefer the nucleosomal substrate.
USP48 is speciﬁc for H2ABRCA1ub. Analysis of USP48
cleavage time courses examined by western blotting conﬁrmed
the observed preference for H2ABRCA1ub over H2A168ub or
H2APRC1ub (Fig. 1c). This analysis surprisingly revealed that
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USP48 cleaves H2ABRCA1ub most efﬁciently if H2A is ubiquiti-
nated on more than one lysine (H2ABRCA1ub3,
H2ABRCA1ub2). To quantify the activity we analyzed cleavage time
courses of H2ABRCA1ub, H2A168ub, or H2APRC1ub on gel using
ﬂuorescence of tetramethylrhodamine (TAMRA)Ub as readout
(Supplementary Fig. 2a). Comparison of the initial linear reaction
rates revealed that H2ABRCA1ub is cleaved with an activated rate,
compared with H2A168ub and H2APRC1ub (Fig. 1d). We conclude
that USP48 shows a preference for H2ABRCA1ub and cleaves its
substrate efﬁciently if more than one ubiquitin is present on the
site. We will refer to the additional ubiquitin needed for activity
as the ‘auxiliary’ ubiquitin, because it aides USP48 cleavage but
itself does not get cleaved.
We wondered how the observed preference for H2ABRCA1ub
translates to a situation where multiple ubiquitination sites are
available for cleavage on a single H2A. To test this we generated
NCPs with an unlabeled ubiquitin conjugated to the polycomb
site and a TAMRAUb conjugated to the BRCA1 site. As expected,
we ﬁnd that USP48 cleaves these substrates with the activated rate
(Fig. 1e). The presence of a ubiquitin on H2APRC1 seems to
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Fig. 1 USP48 speciﬁcally deubiquitinates H2ABRCA1ub. a Schematics of the ﬂuorescence polarization screen. Recombinant nucleosome core particles are
site speciﬁcally ubiquitinated using the E3 ligase named and TAMRAUb. Upon addition of a DUB, cleavage can be followed by a decrease in FP signal. b
USP48 prefers nucleosomal substrates. Site-speciﬁc cleavage of H2A168ub, H2APRC1ub, and H2ABRCA1ub in relation to activity on minimal substrate.
Observed k-values from ﬁtting the raw data of the FP assay (kobs(NCP)) (Supplementary Fig. 1c) were normalized to observed k-values on minimal substrate
(kobs(Rho)) obtained from ﬁtting an exponential function to the traces in Supplementary Fig. 1e). A value above one indicates that NCPs are the preferred
substrate. The mean of two technical replicates ± SEM is shown. c Time course of USP48 cleavage of H2A168ub, H2APRC1ub, and H2ABRCA1ub, anti-H2A
western blotting. USP48 only cleaves efﬁciently when more than one ubiquitin is present on the BRCA1 site. The blot shown is representative of two
experiments. d USP48 cleaves multi-monoubiquitinated H2ABRCA1ub faster than multi-monoubiquitinated H2A168ub and H2APRC1ub. Quantiﬁcation of the
initial reaction velocity (V0) of USP48 measured by the liberation of free TAMRAUb. Gels used for quantiﬁcation are shown in Supplementary Fig. 2a. The
mean of two technical replicates ±SEM is shown. e USP48 does not cleave H2APRC1ub when H2ABRCA1ub is present, but all H2ABRCA1ub is cleaved. Left
panel: cleavage of NCPs, ubiquitinated on PRC1 site with unlabeled ubiquitin, and on the BRCA1 site with TAMRAub by USP48 was followed on gel. The
TAMRA ﬂuorescence is used as readout. Right panel: quantiﬁcation of the initial reaction velocity (V0) measured by liberation of free ubiquitin. The mean
of two technical replicates ± SEM is shown
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further accelerate the cleavage of H2ABRCA1ub. Interestingly, no
H2A monoubiquitinated with TAMRAUb is observed, showing
that unlabeled ubiquitin on the PRC1 site is not cleaved when a
labeled ubiquitin on the BRCA1 site is available. Moreover, on
this substrate all the H2ABRCA1ub is cleaved, suggesting USP48 is
capable of cleaving all H2ABRCA1ub modiﬁcations when an
auxiliary ubiquitin is placed elsewhere on H2A.
We next analyzed potential cleavage of di-ubiquitin linkages,
using USP16 as a positive control (Supplementary Fig. 2b). Of all
the linkages only K27-linked di-ubiquitin was cleaved by USP48.
Moreover, the amount of cleaved di-ubiquitin after 45 min was
negligible compared with the processing of ubiquitin from
modiﬁed nucleosomes. Taken together, our data suggest USP48
is speciﬁc for multi-monoubiquitinated H2ABRCA1ub.
An auxiliary ubiquitin on the nucleosome promotes USP48
activity. To investigate the effect of the auxiliary ubiquitin on
USP48 rates we performed substrate-binding assays combined
with a detailed kinetic analysis and kinetic modeling using the
software KinTek Explorer33,34. We quantiﬁed USP48-catalyzed
cleavage of H2ABRCA1ub under different conditions, achieved by
titrating either USP48 concentration, while keeping substrate
concentration ﬁxed or vice versa. Fig 2a, b show four conditions
as an example in which the substrate concentration is kept steady
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at 2 μM and USP48 concentration is varied between 100 and 12.5
nM. Supplementary Fig. 3 shows the whole range of conditions.
We then tested afﬁnities of USP48 for nucleosomes of different
ubiquitination status and ﬁnd that afﬁnities are essentially the
same for unmodiﬁed nucleosomes (NCP), monoubiquitinated
nucleosomes (H2ABRCA1ub1, generated by ubiquitinating K127 in
a H2AK125/129R mutant) and multi-monoubiquitinated nucleo-
somes (H2ABRCA1ub) in both gel-shift assays and surface plasmon
resonance (SPR) experiments (Fig. 2c, d and Supplementary
Fig. 3b). The gel-shifts show a distinct shift, and formation of
higher molecular weight species at USP48 concentrations above 4
μM. We use the ﬁrst distinct shift to estimate a Kd of 1 μM only,
as the concentrations above 4 μM are never reached in our kinetic
analysis and the effects may be due to artiﬁcial crowding. The
SPR data indicate somewhat higher afﬁnity, as we ﬁt a Kd of
roughly 120 nM and therefore restrain binding between these
values, in the ﬁtting procedure that follows. Importantly, both
SPR and gel-shift experiments show no difference in afﬁnities for
nucleosome species of different ubiquitination status, providing
the rationale to link all binding constants for the kinetic
modeling.
We ﬁtted these binding and kinetic data to the simplest model
that could describe the observed USP48 H2A deubiquitination
pattern (Fig. 2e). We initially set the boundaries for the binding
constants so they would reﬂect the upper and lower limits
measured by gel-shift and SPR assays (1 and 100 nM, respec-
tively). This initial ﬁt determined 1 μM as the apparent Kd for our
model. We then ﬁxed the binding constants of the model to 1 μM
to ﬁt the catalytic rates. The obtained best ﬁt values for kcat(ub3),
kcat(ub2), and kcat(ub1) describe the experimental data well (Fig. 2b
for example and Supplementary Fig. 3 for all experiments) and
are well constrained (Fig. 2f). The kinetic modeling indicates
increased processivity when an auxiliary ubiquitin is present. The
rates for kcat(ub3) (1 s−1) and kcat(ub2) (0.29 s−1) are similar,
whereas kcat(ub1) is roughly 50 times slower (0.0062 s−1). These
results can be explained by a catalytic activation in the presence of
the auxiliary ubiquitin or the inability of USP48 to cleave one of
the three C-terminally ubiquitinated lysines efﬁciently.
To assess a possible role of the UBL domain of USP48 in the
reaction we expressed and puriﬁed USP48 isoform 2 (uniprot
identiﬁer Q86UV5-2/USP48Iso2). The purity of the sample was
similar for both isoforms (Supplementary Fig. 1b). USP48Iso2
lacked residues 909–962, which includes part of the UBL domain
(Supplementary Fig. 4a). Full-length USP48 had signiﬁcantly
higher catalytic rates on both minimal substrate and H2ABR-
CA1ub (Supplementary Fig. 4b, c and Supplementary Table 1).
To compare the kinetic parameters of both isoforms on a
nucleosomal substrate, we repeated the kinetic analysis outlined
before with USP48Iso2 (compare Supplementary Fig. 4d, e and
Fig. 2e, f). The necessity for the auxiliary ubiquitin appears
conserved in both isoforms, whereas catalytic rates are much
higher for full-length USP48.
We further asked whether free ubiquitin could act as the
auxiliary ubiquitin and increase USP48 processivity. To address
this we performed UbRho and H2ABRCA1ub cleavage assays in the
presence and absence of ubiquitin (Supplementary Fig. 3c, d). On
both substrates the addition of free ubiquitin did activate USP48.
This indicates that the auxiliary ubiquitin needs to be on the
nucleosome and possibly in a deﬁned orientation toward USP48,
to cause activation (note that experiments in Supplementary
Fig. 3d are done with USP48Iso2 but both isoforms are expected to
behave the same). In our analysis we regarded afﬁnities measured
by SPR and gel shifts (Fig. 2c, d) as actual substrate afﬁnities.
However, in order to engage the substrate (ubiquitin on H2A) a
reorientation or conformational change of USP48 may occur on
the nucleosome. This step might be masked in our assays as
binding is dominated by the afﬁnities for the nucleosome.
Possible conformational change would be reﬂected in the
calculated kcat values, which include the rate for catalysis and
possible conformational change. Therefore, the detailed analysis
does not yet fully assign the role of the auxiliary ubiquitin, but it
ﬁrmly establishes that some form of activation takes place.
In summary, our biochemical analysis identiﬁed USP48 as a
DUB speciﬁc for nucleosomes ubiquitinated by BRCA1-BARD1,
identifying what is to our knowledge the ﬁrst H2A DUB with
in vitro speciﬁcity for the BRCA1 site. We also demonstrated the
need of an auxiliary, nucleosomal, ubiquitin for USP48 to be fully
active. We next sought to analyze USP48’s importance in cells.
USP48 deubiquitinating activity restrains resection. First, we
addressed whether USP48 could have a role in the DSB response
by evaluating endogenous USP48 localization after DNA damage
caused by micro-irradiation (IR). USP48 co-localized with 53BP1
and BRCA1 along the line of the laser, indicating recruitment to
sites of DNA damage (Fig. 3a). Given the ability of USP48 to
cleave H2ABRCA1ub, we examined whether accumulation of
USP48 at damage sites is dependent on BRCA1 and found that
USP48 recruitment to damaged chromatin was markedly reduced
in BRCA1-depleted cells (Fig. 3a, b).
The BRCA1-BARD1 E3 ubiquitin ligase activity promotes
chromatin remodeling at damaged sites through H2ABRCA1ub
modiﬁcation, which consequently promotes long-range resec-
tion10, RAD51 foci formation, and GC10. Using EdU incorpora-
tion and staining to identify S-phase cells, we examined the role
of USP48 in resection and GC in irradiated cells. USP48-depleted
U20S and HeLa cells exhibited greater numbers of RAD51 foci
formation after IR compared with controls (Supplementary
Fig. 2 USP48 cleavage rates on H2ABRCA1ub are modulated by an auxiliary ubiquitin. a An auxiliary ubiquitin activates USP48 processivity. Gel-based
assay to measure USP48 cleavage of H2ABRCA1ub. TAMRAUb was used as readout. Cleavage was recorded under several different substrate and enzyme
concentrations. Four (stacked) gels are shown as an example (Supplementary Fig. 3 for all gels). b Quantiﬁcation of (a. Four out of 11 different conditions
shown as an example (Supplementary Fig. 3 for full panel). Solid lines show ﬁt obtained by global ﬁtting of all 11 quantiﬁed time courses and binding data to
the model deﬁned in e using Kintek Explorer. c USP48 binds with similar afﬁnities to ubiquitinated and unmodiﬁed NCP. USP48 is titrated to 50 nM of
unmodiﬁed NCP or NCPBRCA1ub and analyzed by native gel-shift assays. A Kd of 1 µM is estimated. d USP48 binds nucleosomes of different ubiquitination
status with the same afﬁnities. Binding of USP48 to H2ABRCA1ub, H2ABRCA1ub1, and unmodiﬁed nucleosomes measured by surface plasmon resonance.
Nucleosomes were immobilized on the surface. Normalized RU values of 10 successive injections of different USP48 concentrations are ﬁtted by a one-
phase binding model using GraphPad Prism (raw data in Supplementary Fig. 3b). Kd and SE of the ﬁt are indicated. e USP48 cleaves H2ABRCA1ub in
nucleosomes 50–150 times faster than when auxiliary ubiquitin is present. Kinetic model describing USP48’s cleavage pattern on H2ABRCA1ub with the
ﬁtted values for kcat(ub3), kcat(ub2), and kcat(ub1), and the SE of the ﬁt. f Parameters for kcat(ub3), kcat(ub2), and kcat(ub1) in e are well constrained by the data.
Evaluation of the goodness of ﬁt. The upper three panels show how well deﬁned the lower and upper boundaries are for the individual parameters. kcat(ub1)
and kcat(ub2) fall into a well-deﬁned local χ2 minimum. For kcat(ub3), the lower boundaries are well deﬁned which allows the conclusion that Kcat(ub3) should
always be faster than kcat(ub1). The lower panel shows how χ2 varies when two of the ﬁtted variables are varied against each other. Red indicates a χ2
minimum
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Fig. 5a, b). Moreover, RAD51 foci were brighter in USP48-
depleted cells (Supplementary Fig. 5c), suggesting more RAD51
molecules per foci as well as greater detection of numbers of foci.
We next assessed the relative contribution of the different USP48
isoforms. Complementation with either small interfering RNA
(siRNA)-resistant wild-type (WT) USP48Iso1 or USP48Iso2
restored RAD51 foci numbers to control levels, suggesting that
despite the difference in catalytic rates both isoforms are capable
of regulating RAD51 foci formation (Supplementary Fig. 5d, e).
In contrast, complementation with the catalytic mutant form of
USP48Iso2 where the catalytic cysteine was mutated to serine
(USP48Iso2-C98S) was unable to restore RAD51 foci numbers to
control levels (Supplementary Fig. 5e).
The ssDNA-binding protein RPA can be used as a marker of
resection before RAD51 exchange, strand invasion, and GC.
Irradiated S-phase cells depleted of USP48 had more RPA foci
compared with controls (Supplementary Fig. 5f, g) and
complementation with either siRNA-resistant USP48Iso1-WT or
USP48Iso2-WT, but not USP48Iso2-C98S, restored RPA foci
numbers to control levels (Fig. 3c, d and Supplementary Fig. 5f,
g). To assess resection itself, we incubated cells with Bromodeox-
yuridine (BrdU) and treated with olaparib before measuring the
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DNA track lengths of the exposed BrdU epitope, indicating
resected ssDNA10,35. Median lengths of ssDNA were longer in
USP48-depleted cells compared with controls (Fig. 3e, f).
Moreover expression of siRNA-resistant USP48Iso1-WT or
USP48Iso2-WT, but not USP48Iso2-C98S, restored resection to
control lengths (Fig. 3e, f). Together, these data suggest that the
catalytic function of USP48 acts to restrain DNA resection
lengths at sites of damage.
USP48 antagonizes the BRCA1-H2Aub-SMARCAD1 resection
pathway. Remodeling of chromatin-associated 53BP1 adjacent to
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DNA DSBs by the BRCA1-BARD1 E3 ubiquitin ligase is medi-
ated by the SWI/SNF-related helicase SMARCAD12. To address
whether USP48 acts in this pathway we tested whether the
increased resection lengths observed on USP48 loss required
BRCA1 or SMARCAD1. As expected10, loss of BRCA1 or
SMARCAD1 shortened ssDNA lengths (Fig. 4a, b) and, sig-
niﬁcantly, these shortened resection tracks were unaffected by
USP48 co-depletion (Fig. 4a). These ﬁndings are consistent with
the idea that USP48 loss has little impact if there is an absence of
the ubiquitin mark to be cleaved or a shortage of the ‘reader’ to
interpret that ubiquitination mark.
Consistent with a model in which the consequences of USP48
loss requires both BRCA1 and SMARCAD1, RAD51 foci
numbers were severely decreased in cells co-depleted for BRCA1,
or SMARCAD1 with USP48 (Fig. 4c, quantiﬁed in Supplementary
Fig. 6a, b). To test BRCA1-dependency further we examined
Rad51 foci in mouse embryonic ﬁbroblasts (MEFs) bearing a
homozygous deletion of murine Brca1 exon 11 (Brca1Δ11/ Δ11). In
WT MEFs, Rad51 foci numbers were increased following murine
Usp48 depletion compared to controls, while in Brca1Δ11/ Δ11
MEFs, which exhibit reduced Rad51 foci numbers36, Usp48
depletion had no effect on Rad51 foci formation (Supplementary
Fig. 6c, d). These data are consistent with a requirement for Brca1
driving increased resection and subsequent Rad51 loading in the
absence of Usp48.
Previous analysis has revealed that over-expression of DUBs
capable of catalyzing the removal of K118/K119 or K13/15-
ubiquitin from H2A, results in disrupted 53BP1 and BRCA1
accumulation30,37. Although we observed that USP48 has little
activity on alternate H2A ubiquitination sites in vitro, we could
not exclude the possibility that USP48 processes these adducts in
cells. However, ectopic expression of USP48Iso1 had no effect on
the ability of cells to form 53BP1 or BRCA1 foci following IR
(Supplementary Fig. 7a, b). These data suggest that USP48 is not
readily able to disrupt damage-signaling dependent on the
H2A168ub modiﬁcation nor, as loss of the PCR1 mark disrupts
BRCA1 and 53BP1 recruitment24, on the H2APRC1ub
modiﬁcation.
We10 and others17 have noted that expression of H2A with
ubiquitin genetically fused to the C-terminus can restore
measures of GC in BRCA1 or BARD1-deﬁcient cells. Such a
fusion lacks an isopeptide bond and is resistant to DUBs. To test
the hypothesis that USP48 acts to cleave ubiquitin from the C-
terminus of H2A in cells we measured the impact of USP48 over-
expression on resection lengths in cells expressing control H2A
and H2A-Ub fusions, labeled H2AKR1-Ub and H2AKR2-Ub (see
Supplementary Fig. 7c, d legend for details). Note previous
analysis has shown ectopic H2A and H2AKR2-Ub are incorpo-
rated into chromatin10. Ectopic expression of USP48Iso2 resulted
in shorter ssDNA lengths (Fig. 4d), consistent with the enzyme’s
ability to restrict resection. However, USP48-induced shortening
of resection lengths was prevented by expression of the H2AKR2-
Ub fusion, but not by H2A (Fig. 4d). Similarly, normal levels of
RAD51 foci were restored by co-expression of either H2AKR1-Ub
or H2AKR2-Ub fusions, but not H2A, in cells over-expressing
USP48Iso1 (Supplementary Fig. 7c, d). These data indicate that a
protease-resistant H2A-Ub renders resection and subsequent
RAD51 foci formation insensitive to the impact of USP48
overexpression, consistent with the enzyme’s function in cleaving
C-terminal H2A modiﬁcations.
BRCA1-BARD1 ligase function contributes to the positioning
of 53BP1 away from the core of IR-induced foci (IRIF)10. To test
the impact of USP48 on 53BP1 positioning, we measured the
distribution of 53BP1 in BRCA1-associated foci in USP48-
depleted cells and observed a greater spread of 53BP1 accumula-
tions compared to controls (half peak intensity width ~ 1.1 μm in
USP48-depleted cells compared with ~ 0.8 μm in controls) and a
larger ‘hole’ at the foci core (53BP1 peak-to-peak distance of ~
0.5 μm USP48-depleted cells, compared to ~ 0.3 μm in controls
Fig. 4e). Thus, consistent with its relationship with BRCA1,
SMARCAD1, H2A-Ub, and resection, USP48 appears to
constrain the extent of 53BP1 repositioning at IRIF.
USP48 restrains HR repair mechanisms. DNA end resection is
the decision point that commits cells to DSB repair by HR-
mechanisms and not NHEJ. Incomplete resection results in
reduced NHEJ and IR-sensitivity, which can be rescued by
inhibiting resection initiation by repressing CtIP38. To assess the
role of USP48 in NHEJ vs. HR, we measured IR sensitivity of
USP48-depleted cells and their ability to reconstitute green
ﬂuorescent protein (GFP) in a NHEJ cut substrate (Supplemen-
tary Fig. 8a). USP48-depleted cells showed a slight reduction in
NHEJ and slightly increased sensitivity to IR (Supplementary
Fig. 8a–c). These small effects were lost when CtIP was co-
depleted (Supplementary Fig. 8d, e), suggesting that the IR-
sensitivity seen in USP48-depleted cells is due to resection. This
minor resection-dependent NHEJ impairment suggests USP48
contributes only in a small way to the decision between HR-
mediated repair and NHEJ.
USP48 loss increases resection and intriguingly, depletion of
USP48 or 53BP1 or their co-depletion, all result in a similar
increase in RAD51 foci (Supplementary Fig. 8f), suggesting that
loss of either protein has a similar impact and acts in the same
pathway to restrict RAD51 accumulation. We therefore assessed
the role of USP48 in GC and SSA-mediated repair. Using the GC
DR3-reporter assay, we measured the formation of GFP products
from the integrated substrate in USP48-depleted cells transfected
with I-Sce139, and complemented with USP48Iso2-WT or
USP48Iso2-C98S (Fig. 5a). GC was increased in USP48-depleted
cells and in USP48Iso2-C98S-complemented cells. These data
show that USP48 activity restrains GC repair. To measured SSA-
mediated repair we used an integrated reporter construct that
depends on extensive resection and SSA for generation of a
Fig. 4 USP48 antagonizes BRCA1-mediated resection. a Increased resection seen on USP48 knockdown requires BRCA1 and SMARCAD1. Resection
lengths were measured in HeLa cells depleted as indicated. Cells were treated with 10mM BrdU for 24 h with addition of 10 µM Olaparib for the ﬁnal 16 h.
Cells were lysed and DNA ﬁbres spread before staining for BrdU-positive single-stranded DNA resection tracks. n= 190 tracks for each condition. Bars
indicate median, also shown numerically in brackets. ***p< 0.005 Mann–Whitney test. b Western blottings to demonstrate protein expression levels in
HeLa cells following siRNA as indicated. c Rad51 foci formation in S-phase (EdU positive) HeLa cells depleted as indicated. Cells were ﬁxed at 2 h post 5 Gy
IR. Scale bars= 10 µm (see Supplementary Fig. 6a, b for quantiﬁcation). d Suppressive impact of USP48Iso2 overexpression on resection lengths can be
rescued by co-expression of an uncleavable H2A-Ub fusion. Resection lengths were measured in untransfected HeLa cells or those transfected with
USP48Iso2 and expressing either H2A or H2A-Ub fusion (KR2 denotes that lysines 13/15, 118/119, and 125/127/129 were mutated to arginines). Cells were
prepared as in a and 210 tracks were measured for each condition. Bars indicate median, also shown numerically in brackets. ***p< 0.005, NS=
nonsigniﬁcant, Mann–Whitney test. e USP48 restricts positioning of 53BP1 in damage foci. Images of BRCA1 and 53BP1 in cells treated with control or
USP48 siRNA exposed to 2 Gy IR and ﬁxed 8 h later. Scale bars= 2 µm. Quantiﬁcation of mean relative intensity proﬁles for co-localizing foci. n= 25, bars
= SEM. Right panel shows western blotting of USP48 protein levels
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functional GFP (illustrated in Fig. 5b)39. USP48 depletion
resulted in increased GFP expression (Fig. 5b), which was
suppressed by complementation with USP48Iso2-WT, but not
USP48Iso2-C98S. Moreover, both the increased GC and SSA
repair seen in USP48-depleted cells required BRCA1, as well as
CtIP (Supplementary Fig. 9a–c). Together, these data suggest that
the role of USP48 DUB activity in restricting extended BRCA1-
mediated resection inﬂuences the outcome of HR at the level of
both GC and SSA.
We next addressed the consequences of USP48 loss on cell
survival following camptothecin exposure, as DSB lesions
produced in this context rely on resection and HR for repair40.
Remarkably, we found USP48-depleted or USP48Iso2-C98S-
complemented cells were more resistant to camptothecin than
DR-GFP
Sce-GFP iGFP GC GFP iGFP
Bcg1Bcg1Bcg1|-Sce1
+I-sce1 +I-sce1
GFPSSASce-3’GFP5’GFP
SA-GFP
|-Sce12.7kb
100
10
1
180
160
140
120
100
80
60
40
20
0
%
 G
en
e 
co
nv
er
sio
n
180
160
140
120
100
80
60
40
20
0
%
 S
SA
 re
pa
ir
Flag-USP48Iso2: – – WT C98S
siRNA: NTC USP48
Flag-USP48Iso2: – – WT C98S
siRNA: NTC USP48
100
10
%
 s
ur
viv
al
%
 s
ur
viv
al
100
10
1
%
 s
ur
viv
al
100
10
%
 s
ur
viv
al
siNTC
siUSP48
siNTC
siUSP48
siUSP48 + Flag-USP48Iso2 WT
siUSP48 + Flag-USP48Iso2 C98SsiUSP48 + EGFP-USP48Iso1WT
0 2 4 6 8 10
Camptothecin (μM)
0 2 4 6 8 10
Camptothecin (μM)
siRNA
RAD52:
RAD51:
USP48:
USP48
RAD51
RAD52*
β-Actin
* Nonspecific band
–
–
–
–
–
+
–
+
–
–
+
+
+
–
–
+
–
+
130
40
35
55
55
siRNA siRNA
NTC
USP48
RAD51
USP48 + RAD51
NTC
USP48
RAD52
USP48 + RAD52
0 2 4 6 8 10
Camptothecin (μM)
0 2 4 6 8 10
Camptothecin (μM)
a b
c d
e f g
Fig. 5 USP48 restrains homology-directed repair mechanisms. a Gene conversion (GC) was measured using U20S DR3-GFP reporter cells as illustrated. It
is noteworthy that the functional GFP cannot be produced by SSA from this substrate as the template iGFP lacks the 5′- and 3′-regions of GFP38. Cells
depleted for USP48 were transfected with RFP, I-Sce1, and either Flag-USP48Iso2-WT or Flag-USP48Iso2-C98S. GFP-positive cells were normalized to RFP-
transfection efﬁciency. %-repair is given compared with NTC. Graph shows mean, n= 5, error bars are SEM. b Single-strand annealing (SSA) was
measured using U20S SA-GFP reporter cells as illustrated. The two GFP fragments of the substrate share 266 nucleotides of homology. In principle GC
with crossing over could also produce functional GFP; however, these have been shown to be rare events39. Cells were treated and analysed as in a. Graph
shows mean, n= 3, error bars are SEM. c, d Camptothecin colony survival curves of HeLa cells depleted for USP48 and complemented with EGFP-
USP48Iso1-WT, n= 3 c or Flag-USP48Iso2-WT or Flag-USP48Iso2-C98S, n= 4 d. Graph shows mean % survival normalized to untreated controls, error bars
are SEM. e Western blottings to demonstrate USP48, RAD51, and RAD52 protein expression levels in HeLa cells following siRNA as indicated. f, g
Camptothecin colony survival curves of HeLa cells depleted for USP48, RAD51, and both USP48 and RAD51 f, and USP48 and RAD52 alone or together g.
Graph shows mean % survival normalized to untreated controls, n= 3, error bars are SEM
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control, or USP48Iso1-WT- or USP48Iso2-WT-complemented
cells (Fig. 5c, d). This increased resistance was lost when
USP48 depletion was accompanied either by BRCA1 or CtIP
co-depletion and instead such cells became highly sensitive to
camptothecin (Supplementary Fig. 9d, e). Likewise, WT-MEFs,
but not Brca1Δ11/Δ11 MEFs, showed a survival beneﬁt in
the presence of camptothecin following Usp48 loss (Supplemen-
tary Fig. 9f). Together these data indicate that camptothecin
resistance through USP48 loss requires resection and BRCA1.
Finally, we explored the mechanisms of resistance in USP48-
depleted cells. As expected, the sensitivity of both control
and USP48-depleted cells to camptothecin was increased
by depletion of RAD51 (Fig. 5e, f), indicating HR-GC contributes
to camptothecin resistance. As the annealing of ﬂanking
repeats in SSA uses RAD5241–43, we next assessed the contribu-
tion of SSA to camptothecin resistance by silencing RAD52
expression. Intriguingly, and in contrast to RAD51 depletion,
RAD52 depletion had little impact on camptothecin sensitivity in
control cells, but dramatically increased camptothecin sensitivity
in USP48-depleted cells (Fig. 5e, g). Thus, a proportion of the
camptothecin resistance seen on USP48 loss stems from a reliance
of these cells on HR repair by SSA, which is not utilized in cells
expressing USP48.
Discussion
The data we present here establishes USP48 as a DUB that
antagonizes the BRCA1 ligase function. We show that
USP48 speciﬁcally counteracts BRCA1-initiated H2A ubiquiti-
nation. By limiting the extent of this ubiquitination mark
USP48 affects the positioning of 53BP1 at damaged chromatin
through SMARCAD1 and thus limiting resection length.
We propose that the likely function of USP48 is to ﬁne tune
resection length and to avoid over-resection and mutagenic
SSA. On a mechanistic level, we show that USP48 needs an
auxiliary ubiquitin on the substrate to be activated, possibly
allowing cross-talk between different ubiquitination sites
generated by different ligases.
Methodologically, the FP assay we developed to measure site-
speciﬁc deubiquitination allows rapid qualitative assessment of
DUB site speciﬁcity. Quantiﬁcation is complicated by variables
inﬂuencing the FP signal, such as DUBs binding to free ubiquitin
that changes FP properties; in addition, the ubiquitinated NCPs
present a very heterogeneous substrate with a mix of mono-, di-,
and tri-ubiquitinated H2A, further complicating the analysis.
Nevertheless, as a qualitative measure the assay could be extended
to other ubiquitinated substrates.
Under the conditions tested, most DUBs do not show site or
substrate speciﬁcity, as they cleave both NCP and minimal sub-
strate. In most cases, the minimal substrate is cleaved more
efﬁciently, which suggests that nucleosomes are not the preferred
target. With many other ubiquitinated proteins in the cell that are
potentially better targets there might not be a need for clear cut
substrate speciﬁcity as relative enzyme and substrate concentra-
tions in a given situation will decide which target is cleaved.
Participation in protein complexes and possible post-translational
modiﬁcations will add another layer of regulation as reported for
many DUBs44.
Besides the enzymes tested there may be speciﬁc DUBs that
were not included in this study, such as USP51, which has been
reported to be speciﬁc for H2A168ub 45. Of the DUBs we did test
USP48 seems to be unique in showing clear intrinsic substrate
speciﬁcity. Our biochemical analysis suggests that USP48 is spe-
ciﬁc for H2A ubiquitinated by BRCA1-BARD1.
Interestingly, USP48 reaches its full catalytic potential when
more than one lysine on the BRCA1 site is ubiquitinated or when
ubiquitin is located at the polycomb site at K119. A similar
requirement for multiple ubiquitination events has been reported
for the proteasome-associated DUB USP1446, which cleaves
supernumerary chains. However, it is not clear whether USP14
cleaves any target with multiple sites ubiquitinated or only
selected substrates, a question that can be extended to USP48.
Our data suggest that USP48 is fully active on H2ABRCA1ub, but
not on H2APRC1ub nor H2A168ub, showing that it indeed only
acts on a selected substrate. This suggests a two-fold regulatory
switch for USP48: the ﬁrst being the intrinsic target speciﬁcity for
the BRCA1 site on the nucleosome and the second the depen-
dence on the auxiliary ubiquitin for full catalytic activation.
Although USP14 cleaves supernumerary chains marking targets
for degradation, we show that USP48 can cleave signaling
monoubiquitination highlighting that a similar regulatory
mechanism is employed in two profoundly different pathways. In
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Fig. 6 Model of USP48 function in restricting extended DNA end resection.
a USP48 cleaves the C-terminal ubiquitin modiﬁcation of H2A, limiting the
extent of SMARCAD1 nucleosome remodeling and 53BP1 positioning.
53BP1 in turn restrains DNA end processing and consequently direct
repeats are rarely exposed either side of the DSB, favoring GC (one side of
the break is illustrated). Without USP48 activity, H2A modiﬁcation is
unopposed and SMARCAD1 nucleosome remodeling is extended further
from the break, resulting in 53BP1 positioning further from the break site.
53BP1 is unable to constrain extended resection, resulting in increased GC,
and, as repeats either side of the break are more often exposed, SSA is also
increased. b USP48 cannot cleave BRCA1-initiated H2A monoubiquitination
efﬁciently, therefore SMARCAD1 can bind and initiate downstream
signaling. c A second ubiquitination on H2A can activate USP48, cleaving
BRCA-initiated ubiquitination; therefore, SMARCAD1 cannot engage with
the nucleosome anymore and signaling is stopped
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cells recruitment of USP48 requires BRCA1, but in vitro there is
no additional afﬁnity for ubiquitin-modiﬁed over unmodiﬁed
nucleosomes, suggesting that the mechanism of accumulation
may not necessarily be at the level of ubiquitin binding. It is
possible that other BRCA1-mediated events encourage USP48
recruitment, but these remain to be explored.
In cells we show that resection directed by BRCA1-BARD1 can
be countered by the DUB activity of USP48. Manipulation of
USP48 has striking consequences for DNA end resection and cell
survival following exposure to camptothecin. Without USP48
activity cells exhibit increased DNA resection, which is dependent
on BRCA1 and the remodeler SMARCAD1. Moreover consistent
with our previous report10 that BRCA1 and subsequent SMAR-
CAD1 activity acts to determine 53BP1 positioning around DNA
break sites, USP48 loss results in even greater spread of 53BP1 at
IRIF. Remarkably, these molecular events appear to be reﬂected
in the increased use of both GC and SSA in USP48-depleted cells.
Indeed, we show that increased camptothecin resistance seen in
USP48-depleted cells is dependent on RAD51 and on RAD52,
indicating use of SSA in USP48-depleted cells not present in
controls. Conversely, overexpression of USP48 drastically short-
ens resection lengths in a manner that can be reversed by
expression of a protease resistant H2A-Ub fusion. That chro-
matin remodeling at damaged sites is capable of promoting
extended resection is supported by previous reports. For example,
in yeast the SMARCAD1 ortholog Fun30, which acts to counter
Rad9, can promote hyper-resection when tethered artiﬁcially to
chromatin47. In this case, extended resection appears to be due to
improved targeting of Fun30 to damaged chromatin and
uncoupling it from cell cycle control47. Similarly, in human cells,
extended resection is observed in the absence of 53BP1, or its
recruitment pathway9,48–51, and RAD52-dependent SSA becomes
the dominant repair pathway51.
Our data suggest a model in which USP48-mediated removal
of the H2ABRCA1ub mark on chromatin restrains subsequent
SMARCAD1 function, thereby halting the mobilization of 53BP1
and providing a boundary for resection (Fig. 6a). In this model
the opposing activities of BRCA1-BARD1 vs. USP48 determine
local H2ABRCA1ub modiﬁcations and consequently, in the pre-
sence of 53BP1, are capable of directing the degree of DNA end
resection. We speculate that when USP48 is absent, H2A mod-
iﬁcation is sustained even at low levels of BRCA1-BARD1 accu-
mulation so that SMARCAD1-mediated nucleosome sliding or
H2A/B eviction52 extends more widely from damaged sites than
in controls.
The observation that a H2A-Ub fusion rescues USP48 over-
expression phenotypes is intriguing in the light of our biochem-
ical data indicating USP48 needs an auxiliary ubiquitin for
efﬁcient cleavage. Although it is clear that the H2A-Ub fusion
requires SMARCAD1 to restore markers of HR in BRCA1-
deﬁcient cells10, the precise requirements for SMARCAD1’s
reading of the H2A-Ub C terminus are not yet known. It is
possible that the C-terminally linked ubiquitin fusion, due to its
orientation and accessibility, is an efﬁcient signaling entity and
thus alleviates the need for an additional ubiquitin to initiate
signaling on the endogenous substrate. Alternatively, the results
may indicate that one ubiquitin on the BRCA1 site is enough to
initiate signaling but a second, auxiliary ubiquitin is needed to
switch it off, through activation of USP48. This is an intriguing
model given recent data suggesting that BRCA1 activity is evo-
lutionarily “underpowered”53 and thereby implying that too much
activity may be toxic. Such a model would suggest two distinct
ubiquitination sites: a signaling site responsible for SMARCAD1
recruitment and an auxiliary site, activating USP48 to cleave the
ubiquitin on the signaling site. The auxiliary ubiquitin could be
conjugated to one of the two unoccupied lysines on the
BRCA1 site or may be placed by another E3 ligase on a different
site, possibly by the PRC1 E3 ligase, at K118/119, providing a
potential step in the observed crosstalk between DNA damage
and transcriptional regulation (Fig. 6b, c)23,54,55.
Our data supports the idea of a continuum between increased
resection that promotes GC and hyper-resection leading to SSA
as we see both an increase in RAD51 foci and GC repair out-
comes as well as increased SSA and RAD52 dependency when
USP48 is inactive or reduced. Although one model suggests ever
longer ssDNA lengths may promote SSA over GC, another pos-
sibility is that a proportion of hyper-resection does not reveal
direct repeat sequences either side of the break and thus
encourages GC, whereas other extended track lengths expose such
sequences and SSA results.
Repetitive elements are numerous in the human genome so
that restricting SSA would be expected to be signiﬁcant in pre-
venting large-scale rearrangements that cause deletions of
sequences located between the repeats. Thus, high levels or
activity of USP48 would be expected to decrease resection lengths
and thus reduce GC, and phenocopy aspects of BRCA1 loss. In
contrast USP48 loss or decreased activity would be expected to
increase resection lengths and favor SSA. Both outcomes might be
expected to be mutagenic. Evidence that increased SSA is asso-
ciated with cancer, come, e.g., from the examination of T-cell
lymphoma in Ataxia Telangiectasia Mutated TM-deﬁcient mice,
which is suppressed following Rad52 deletion56. We predict that
an imbalance in the BRCA1-BARD1-USP48 circuit could have
deleterious consequences for genome stability and be signiﬁcant
in the prevention or progression of cancer.
Finally, these data also suggest a further mode of resistance
against poly (adenosine diphosphate [ADP]) ribose polymerase
(PARP) or topoisomerase inhibitor treatment in cancer therapy.
However, in contrast to 53BP1 loss, which can restore HR repair
to BRCA1-deﬁcient tumors, USP48 loss is not an expected
mechanism of tumor resistance in BRCA1 patients as hyper-
resection following USP48 loss requires BRCA1 function.
Nevertheless, USP48 loss of function would be expected to
increase the resistance of tumors in which the BRCA1-resection
pathway is intact to agents that force a reliance on HR-mediated
repair.
Methods
Plasmids. Flag-HA-USP48 isoform 2 was a gift from Wade Harper (Addgene
plasmid 22585). RNF168 RING domain (1–113) was cloned into pETNKI-His-
SUMO2-LIC-kan. Plasmids for RING1b(1–159)/BMI1(1–109) RING domain
expression were described in ref. 57. UBCH5C (UBE2D3) plasmid was a gift from P
Jackson (Stanford University School of Medicine). BRCA1 and BARD1 constructs
inpCOT7N vector were a gift from Rachel Klevit (University of Washington).
USP15 and USP11 cDNA were a gift from Hidde Ploegh (Whitehead Institute for
Biomedical Research). USP12 and UAF1 plasmids were a gift from Martin Cohn
(University of Oxford). For recombinant protein expression in insect cells USP15,
USP16, USP48, and BAP1 were cloned into pFastBacNKI-his-3C-LIC, USP1,
USP3, and USP12 were cloned into the pFastBacHTb vector. UAF1 was cloned into
pFastBac1. USP7 was cloned into pGEX6p-1 vector and expressed in Escherichia
coli. USP11 was cloned into pET-NKI His-3C-LIC58 vectors and expressed in E.
coli.
Cloning USP48 isoform 1. USP48 isoform 1 was cloned from an isoform 2
construct by inserting the missing piece using a gene block (IDT/ sequence in
Supplementary Table 2). USP48 isoform 1 was then cloned into pFastBacNKI-his-
3C-LIC for expression in insect cells.
For experiments in cells, USP48 isoform 2 was cloned into pcDNA5/FRT/TO
with addition of an N-terminal FLAG tag and USP48 isoform 1 cloned pcDNA5.1/
FRT/TO puro(N)GFP Tobacco Etch Virus cleavage site (TEV) FLAG 3C. Point
mutations to generate siResistance against both USP48-Ex5 and USP48-Ex11
siRNA sequences were generated for both isoforms and FLAG-USP48Iso2 catalytic
dead (C98S) were made by site-directed mutagenesis. All constructs were
conﬁrmed by sequencing (Source Biosciences).
All primers used for cloning and mutagenesis are given in Supplementary
Table 2. HA-H2A and HA-H2AKR2-Ub (H2A-K13,15,118,119,125,127,129R-Ub-
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Kless) were described previously10 and all H2A constructs including HA-H2AKR1-
Ub (H2A-125,127,129R-Ub-Kless) were originally synthesized by Genscript.
Protein expression and puriﬁcation. All E. coli cells were grown in Lysogeny
broth (LB) medium and all Sf9 insect cells in serum-free InsectXpress medium
(BioWhittaker) supplemented with Penicillin/Streptomycin/Amphotericin
(BioWhittaker).
Ubiquitin. Protein was puriﬁed from E. coli. Cells were grown at 37 °C until an
optical density (OD) of 0.8 was reached and then induced with 400 μM Isopropyl
β-D-1-thiogalactopyranoside (IPTG). Protein was expressed for h hours at 28 °C.
Cells were collected in lysis buffer (50 mM TRIS pH 7.5, 150 mM NaCl, 1 mM
TCEP, 2 mM Imidazole) with Complete EDTA-free protease inhibitor (Sigma) and
lysed by sonication. Lysate was cleared by spinning down at 21,000 × g. Perchloric
acid (2%) was slowly added to the supernatant while stirring on ice. The sample
was cleared again by centrifugation at 20,000 × g and the supernatant was dialyzed
against 50 mM ammonium acetate pH 4.5. The sample was then loaded on a SP HP
column (GE Healthcare) and eluted with a linear salt gradient ranging from 0 to
500 mM NaCl. The sample was subsequently puriﬁed on a Superdex75 size
exclusion column (GE Healthcare) in 50 mM TRIS pH 8.0 and 100 mM NaCl.
hUBA1. Protein was expressed in E. coli. Cells were grown at 37 °C until an OD of
0.8 and then induced with 200 μM IPTG. Temperature was set to 18 °C and protein
was expressed overnight. Cells were collected in lysis buffer (50 mM TRIS pH 8,
100 mM NaCl, 1 mM β-mercaptoethanol) with Complete EDTA-free protease
inhibitor (Sigma) and lysed by sonication. Lysate was cleared by spinning down at
21,000 × g and loaded on TALON beads (Clontech Laboratories, Inc.). Beads were
washed with 20 complete volumes of lysis buffer +6 mM Imidazole and eluted in
lysis buffer + 300 mM Imidazole. Sample was diluted to 50 mM NaCl and injected
into a Resource Q anion exchange column (GE Healthcare). Protein was eluted
using a linear salt gradient ranging from 50mM NaCl to 600 mM NaCl. In a ﬁnal
step, the sample was puriﬁed on a Superdex 200 size exclusion column (GE
Healthcare) in lysis buffer. Samples were concentrated and stored at − 80 °C.
UBCH5C(UBE2D3). Protein was expressed in E. coli. Cells were grown at 37 °C
until an OD of 0.8 and then induced with 200 μM IPTG. Temperature was set to
18 °C and protein was expressed overnight. Cells were collected in lysis buffer (50
mM TRIS pH 7.5, 150 mM NaCl, 1 mM TCEP, 2 mM Imidazole) with Complete
EDTA-free protease inhibitor (Sigma) and lysed by sonication. Lysate was cleared
by spinning down at 21,000 × g and loaded on TALON beads (Clontech Labora-
tories, Inc.). Beads were washed with 20 CV of lysis buffer + 6 mM Imidazole and
eluted in lysis buffer + 300 mM Imidazole. His-tag was cleaved overnight at 4 °C
with 3 C protease, dialyzing against gel ﬁltration buffer (25 mM HEPES pH 8, 150
mM NaCl, 5 mM dithiothreitol (DTT)). Protease and uncleaved protein were
removed using TALON beads and sample was puriﬁed by size exclusion chro-
matography on a Superdex 75 16/60 column (GE). Samples were concentrated and
stored at − 80 °C.
RNF168 RING domain (residues 1–113). Protein was expressed in E. coli. Cells
were grown at 37 °C until an OD of 0.6 and the induced with 200 μM IPTG.
Temperature was set to 18 °C and protein was expressed overnight. Cells were
collected in lysis buffer (50 mM TRIS pH 8, 500 mM NaCl, 1 μM ZnCl2,1 mM
TCEP, 2 mM Imidazole) with Complete EDTA-free protease inhibitor (Sigma) and
lysed by sonication. Lysate was cleared by spinning down at 21,000 × g and loaded
on TALON beads (Clontech Laboratories, Inc.). Beads were washed with 20 CV of
lysis buffer + 10 mM Imidazole and eluted in lysis buffer + 300 mM Imidazol. His-
Sumo tag was cleaved overnight with SENP protease at 4 °C dialyzing against
dialysis buffer (50 mM TRIS pH 8, 250 mM NaCl, 1 μM ZnCl2,1 mM TCEP).
Protease, uncleaved sample, and His-Sumo were removed with TALON beads.
Sample was diluted to a salt concentration of 50 mM NaCl and loaded onto a
Heparin column (GE). Sample was eluted with a salt gradient ranging from 50 to
1,000 mM NaCl in 12 CV. Fractions containing RNF168 were combined and
further puriﬁed by size exclusion chromatography using a Superdex 75 16/60
column (GE Healthcare) in 50 mM TRIS pH 8, 150 mM NaCl, 1 μM ZnCl2, and 1
mM TCEP. Samples were concentrated and stored at − 80 °C.
RING1b/BMI1 RING domain. Puriﬁcation of RING1b/BMI1 RING domain con-
structs was done as described before57 with slight changes. E. coli cells were grown
at 37 °C until an OD of 0.8 was reached and then induced using 200 μM IPTG.
Protein was expressed over night at 18 °C. Cells were collected in the morning in
lysis buffer (50 mM TRIS pH 7.5, 150 mM NaCl, 2 μM ZnCl2, 1 mM DTT) and
lysed by sonication. Lysate was cleared by spinning at 21,000 × g and supernatant
was loaded on glutathione sepharose beads (GE Healthcare). The beads were
washed with 200 ml lysis buffer and protein was eluted using 20 ml lysis buffer +
20 mM glutathione. The glutathione S-transferase (GST) tag was cleaved overnight
using 3C protease at 4 °C. The cleaved sample was puriﬁed on a Superdex 75 16/
60 size exclusion column in lysis buffer with a GST-trap ﬁtted at the end to remove
uncleaved protein and free GST. Samples were concentrated and stored at − 80 °C.
BRCA1-BARD1 RING domain. BRCA1 (1–303) and BARD1 (1–306) were co-
expressed in E. coli. Cells were grown in LB at 37 °C until OD of 0.6 was reached
and then induced with 100 μM IPTG. Protein was expressed for 4 h at 37 °C. Cells
were collected in lysis buffer (25 mM HEPES pH 7.5, 150 mM NaCl, 1 mM TCEP,
5 mM Imidazole) and lysed by sonication. Lysate was cleared by spinning at
21,000 × g and supernatant was loaded onto chelating sepharose beads (GE
healthcare) charged with Ni2+ in gravity ﬂow columns. Beads were washed with 20
CV lysis buffer + 30 mM Imidazole. Protein was eluted in lysis buffer + 300 mM
Imidazole. Salt concentration was diluted to 50 mM NaCl and sample was loaded
on a Resource S cation exchange column (GE Healthcare). Protein was eluted with
a salt gradient (50–1,000 mM NaCl, 25 mM HEPES pH 7.5, 1 mM TCEP) and
fractions containing BRCA1-BARD1 were pooled. Pooled fractions were further
puriﬁed by size exclusion chromatography on a Superdex 75 column (GE
Healthcare). Samples were concentrated and stored at − 80 °C.
USP1/UAF1complex. Proteins were expressed and puriﬁed as described in ref. 59.
Proteins were coexpressed by Baculovirus expression in Sf9 insect cells. Cells were
infected at a density of 1 × 106 cells per ml and grown for 72 h. Cells were collected
in lysis buffer (50 mM TRIS pH 8, 150 mM NaCl, 2 mM TCEP) and complete
EDTA-free protease inhibitor (Sigma) was added. Cells were lysed by sonication
and sample was cleared by centrifugation at 21,000 × g for 30 min. Supernatant was
loaded on His-afﬁnity column (GE Healthcare) and column was washed with lysis
buffer + 50 mM Imidazol. Sample was eluted with 500 mM Imidazol. The eluted
sample was then loaded on a Strep-afﬁnity column (IBA Life Science) and eluted
using lysis buffer + 2.5 mM desthiobiotin. The sample was then puriﬁed on a
Superdex 200 size exclusion column (GE Healthcare) in lysis buffer. Samples were
concentrated and stored at − 80 °C.
USP7. Protein was expressed in BL21(DE2)Rosetta2 cells. Cells were grown at 37 °
C in Terriﬁc Broth until an OD of 1.8–2.0 and induced with 100 μM IPTG.
Temperature was set to 18 °C and protein was expressed overnight. Cells were lysed
using Emulsiﬂex in lysis buffer (50 mM HEPES pH 7.5, 250 mM NaCl, 1 mM
EDTA, 1 mM DTT) + 0.1 mM phenylmethylsulfonyl ﬂuoride and 1 mg DNAse1.
Lysate was cleared by centrifugation at 20,000 × g and supernatant was loaded on
Glutathione Sepharose 4B beads (GE Healthcare) in gravity ﬂow column. Beads
were washed in lysis buffer and eluted in lysis buffer + 15 mM reduced glutathione.
GST-tag was cleaved overnight with 3C protease dialyzing against 10 mM HEPES
pH 7.5, 50 mM NaCl, 1 mM EDTA, 1 mM DTT. Sample was puriﬁed using a
ResourceQ anion exchange column (GE Healthcare) using a salt gradient (50–500
mM NaCl, 10 mM HEPES pH 7.5, 1 mM DTT). USP7 containing fractions were
pooled and further puriﬁed by size exclusion chromatography on a Superdex 200
column (GE Healthcare). Samples were concentrated and stored at − 80 °C.Please
spell out TB in text, as it is mentioned only once.in text
USP11. Protein was expressed in E. coli and puriﬁed as described before60. USP11
was expressed in BL21(DE3) E. coli cells. Cells were grown in LB at 37 °C until an
OD of 0.8 was reached and were then induced with 200 μM IPTG. Protein was
expressed overnight at 20 °C. Cells were collected in lysis buffer (20 mM TRIS pH
7.5, 150 mM NaCl, 5 mM β-mercaptoethanol) and lysed by sonication. Sample was
cleared by centrifugation at 21,000 × g for 30 min and the supernatant was loaded
on chelating sepharose beads charged with Ni2+. Beads were washed with lysis
buffer and sample was eluted in lysis buffer + 350 mM Imidazol.
USP12. Same puriﬁcation as for USP1/UAF1 until the elution from the His-afﬁnity
column. For USP12 the His-tag was then cleaved overnight using TEV protease,
while dialyzing against lysis buffer overnight. After cleavage, the sample was ﬂown
over a His-afﬁnity column again to remove uncleaved protein and protease (sample
was collected from the ﬂow through). The sample was then puriﬁed on a Superdex
200 size exclusion column (GE Healthcare) in lysis buffer. Samples were con-
centrated and stored at − 80 °C.
USP15, USP16, and USP48 (isoform1 and 2). Proteins were expressed in Sf9
insect cells for 48–72 h (until viability dropped below 90 %). Cells were lysed by
sonication in 25 mM HEPES pH 7.5, 300 mM NaCl, 2 mM DTT, and 5 mM
Imidazole supplemented with Pierce EDTA-free protease inhibitor (Thermo
Fisher). Lysate was cleared by centrifugation at 21,000 × g at 4 °C and the super-
natant was loaded on chelating sepharose beads (GE) charged with Ni2+. Beads
were washed with 20 column volume of lysis buffer + 30 mM Imidazole and then
eluted in lysis buffer + 300 mM Imidazole. The His-tag was cleaved using His-
tagged 3C protease overnight at 4 °C, while dialyzing against 25 mM HEPES 7.5,
150 mM NaCl, 1 mM DTT. The sample was then run over chelating sepharose
beads charged with Ni2+ to remove protease and uncleaved sample, and subse-
quently puriﬁed by size exclusion chromatography using a Superdex S200 16/60
column (GE) in 25 mM HEPES 7.5, 150 mM NaCl, 1 mM DTT. Samples were
concentrated and stored at − 80 °C.
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USP3. Same as USP48 but with 500 mM NaCl and 1 μM ZnCl2 in the lysis buffer
and TEV protease was used to cleave the tag. Samples were concentrated and
stored at − 80 °C.
BAP1. The protein was expressed in SF9 insect cells using the Baculovirus
expression system as described in ref. 61. Cells were infected for 72 h and collected
in lysis buffer (50 mM TRIS pH 8.0, 200 mM NaCl, 50 mM Imidazol, 0.5 mM
TCEP) supplemented with complete EDTA-free protease inhibitor (GE Health-
care) and lysed by sonication. The lysate was cleared by centrifugation at 20,000 × g
and the supernatant was loaded on chelating sepharose beads (GE Healthcare)
charged with Ni2+. Beads were washed in 15 column volumes wash buffer and
eluted in elution buffer (20 mM TRIS pH 8.0, 150 mM NaCl, 500 mM Imidazole
pH 8.0, 10% Glycerol, 0.5 mM TCEP). The sample was then puriﬁed on an anion
exchange column (Poros HQ, Applied Biosystems). The sample was applied in 20
mM TRIS pH 8.0, 50 mM NaCl, 5% Glycerol, 0.5 mM TECP, and eluted using a
linear salt gradient ranging from 50 to 750 mM NaCl. The sample was then further
puriﬁed on a Superrose 6 size exclusion column (GE Healthcare) in 10 mM HEPES
pH 7.5, 150 mM NaCl, 10 % Glycerol, 0.5 mM TCEP. Samples were concentrated
and stored at − 80 °C.
ASXL1 (1–390). Protein was expressed and puriﬁed as described in ref. 61. The
protein was expressed in E. coli. Cells were grown at 37 °C until an OD of 0.6 was
reached and then induced with 500 μM IPTG. The protein was expressed at 25 °C
for 4–6 h. The cells were collected in lysis buffer (50 mM Tris pH 8.0, 200 mM
NaCl, 50 mM Imidazole pH 8.0, 0.5 mM TCEP) supplemented with complete
EDTA-free protease inhibitor (GE Healthcare) and lysed by sonication. The lysate
was cleared by centrifugation at 20,000 × g and the supernatant was loaded on
chelating sepharose beads (GE Healthcare) charged with Ni2+. The beads were
washed in 10 column volumes of lysis buffer and the sample was eluted in 20 mM
Tris pH 8.0, 100 mM NaCl, 500 mM Imidazole pH 8.0, 10% Glycerol, and 0.5 mM
TCEP. The sample was then puriﬁed by cation exchange chromatography on a
Poros HS column (Applied Biosystems). The sample was applied in 20 mM Bis-
Tris pH 6.5, 50 mM NaCl, 5% Glycerol, 0.5 mM TCEP, and eluted with a linear salt
gradient ranging from 50 to 750 mM NaCl. In a ﬁnal step the sample was puriﬁed
by size exclusion chromatography on a Superdex 75 column (GE Healthcare) in 10
mM HEPES pH 7.5, 150 mM NaCl, 10 % Glycerol, 0.5 mM TCEP.
Nucleosome reconstitution. Histones and 147 bp DNA with Widom601 strong
positioning sequence were puriﬁed, octamers folded, and nucleosomes recon-
stituted by salt dialysis as described previously62,63. To assemble the Octamer
puriﬁed recombinant histones were combined at equimolar concentrations (20
μM) and dialyzed against three changes of 2 l of refolding buffer (20 mM TRIS pH
7.5, 2 M KCl, 5 mM β-mercaptoethanol, 1 mM EDTA). Octamers were then pur-
iﬁed by gel ﬁltration on a Superdex 200 column (GE Healthcare) in refolding
buffer. NCPs assembled by combining Octamer and DNA at a ratio of 1 : 0.9 (using
7 μMOctamer), adjusting the salt concentration so it is kept at 2 M KCl at all times.
The samples were then dialyzed against 10 mM TRIS pH 7.5, 2 M KCl, 1 mM
EDTA, 1 mM DTT at 4 °C. The salt concentration was then lowered gradually to
250 mM KCl over a period of 18 h. Finally, the sample was dialyzed against 20 mM
TRIS pH 7.5, 150 mM NaCl, 1 mM DTT for 4 h (or overnight) at 4 °C.
Cell lines. Flp-In Doxycyclin-inducible HeLa parent cell lines were a gift from
Grant Stewart, University of Birmingham, and were clonally selected in the Morris
lab for Tet-Inducible expression. FlpIn HeLa cell lines were grown in DMEM
(Sigma), 10 % Tetracycline-Free Fetal Calf serum (Clontech) supplemented with 1
% penicillin/streptomycin. All other cell lines were grown in DMEM supplemented
with 10% fetal calf serum (Sigma) and 1 % penicillin/streptomycin. Mycoplasma
testing was by Hoechst DNA staining. Stable doxycycline-inducible cell lines were
made by co-transfection of pcDNA5/FRT/TO-FlagUSP48Iso2-siResistant-WT or
-C98S constructs with pOG44 recombinase into HeLa-FlpIn cells. Clones were
selected in hygromycin (400 μg ml−1) and expanded. Flag-USP48 expression fol-
lowing 48–72 h induction with doxycycline (1 μg ml−1) was conﬁrmed by western
blotting. HeLa-FlpIn EGFP-USP48Iso1 cells were made likewise in the Sixma lab.
Brca1Δ11/Δ11 MEFs were a kind gift of Andre Nussenzweig (National Cancer
Institute National Institutes of Health, Rockville USA). WT MEFs were generated
in the Morris lab. U20S-GFP reporter cell lines for GC (DR3), NHEJ (EJ5), and
SSA were a kind gift from Jeremy Stark (City of Hope, Duarte, CA).
Transfections. siRNA transfections were performed using Dharmafect1 (Dhar-
macon) and DNA plasmids using FuGENE 6 (3 µl:1 µg FuGENE:DNA) (Promega)
following the manufacturer’s protocols. Cells were grown for 48 h post transfection
before treatment and collection. With the exception of Supplementary Fig. 5a, all
siRNA against USP48 was a combination of USP48-Ex5 and USP48-Ex11 siRNA
sequences. All siRNA sequences are given in Supplementary Table 3.
Western blottings. A full list of antibodies used for western blottings can be found
in Supplementary Table 4. Uncropped western blottings are shown in Supple-
mentary Fig. 10.
Kinetics on minimal substrate Ubiquitin-Rhodamine. Ubiquitin linked to a
cleavable small peptide labeled with Rhodamine (UbRHO, UbiQ) was used as a
substrate. Reaction was followed through increase of ﬂuorescence intensity at 590
nm due to liberation of free ﬂuorescent Rhodamine from the quenched substrate
upon cleavage by a DUB. The assays were done in 384-well plates (Corning, ﬂat
bottom, low ﬂange) in a Pherastar plate reader (BMG Labtech) at 30 °C using an
assay buffer of 25 mM HEPES pH 7.5, 150 mM NaCl, 5 mM DTT, and 0.05 %
TWEEN-20. For full Michaelis–Menten analysis substrate was titrated starting
from 30 μM in eight two-fold dilutions, whereas enzyme concentration was kept
constant. Enzyme concentrations are indicated in Supplementary Fig. 1. Cleavage
was started by addition of the respective DUB. The initial velocity of the reaction
was calculated from the slope of the linear phase of the curve and was plotted
against the substrate concentration and ﬁtted to the Michaelis-Menten equation
using the program GraphPad Prism.
For single point assays (Supplementary Fig. 1e), 2 μM of substrate and different
concentrations of enzyme were used. Assays were done at 30 °C. The different
enzyme concentrations are indicated in the ﬁgure.
Fluorescent labeling of ubiquitin. Ubiquitin with a cysteine residue introduced at
the N terminus right after the methionine at position 1 was labeled using
maleimide-linked TAMRA dye. Ubiquitin (250 μM) was labeled with 1500 μM
TAMRA (5)-Maleimide (Setareh) at 4 °C overnight. Excess dye was removed by
size exclusion chromatography using a Superdex 75 16/60 column (GE) in 50 mM
TRIS pH7.5, 150 mM NaCl, and 1 mM DTT.
Ubiquitination assay. Nucleosomes were ubiquitinated using 0.5 μM hUBA1, 1
μM UbcH5C (UBE2D3), 1 μM E3 RING domain (RNF168, RING1B/BMI1, or
BRCA1-BARD1), 5 μM NCP, 20 μM ubiquitin or TAMRAUb, and 3 mM ATP in 25
mM HEPES pH 7.5, 150 mM NaCl, 3 mM MgCl2, and 1 mM DTT for 60 min at 30
°C. Substrates for Fig. 1c were ubiquitinated for 40 min, all the others for 60 min (as
stated). Ubiquitinated NCPs were then gel ﬁltered on a Superose 6 Increase column
using the Akta micro puriﬁer system (GE) in 25 mM HEPES pH 7.5, 150 mM
NaCl, 1 mM DTT.
Double ubiquitination at polycomb and BRCA1 site. NCPs containing the H2A
K118R were used to assure only K119 is ubiquitinated by RING1B/BMI1. Mutant
NCP were ubiquitinated with RING1B/BMI1RING and gel ﬁltered on the Superose
6 increase using the Akta micro puriﬁer system (GE Healthcare). Puriﬁed NCP
ubiquitinated at K119 were then ubiquitinated a second time using BRCA1-
BARD1RING and TAMRAUb, generating NCP ubiquitinated on K119 with unlabeled
ubiquitin and on the BRCA1 site with TAMRAUb.
FP assay to measure DUB activity. FP assays were done in 384-well plates
(Corning, ﬂat bottom, low ﬂange) in a Pherastar plate reader (BMG Labtech) at 30
°C using an assay buffer of 25 mM HEPES pH 7.5, 150 mM NaCl, 5 mM DTT, and
0.05 % TWEEN-20 (Sigma). NCPs ubiquitinated with TAMRAUb on either of the
three sites were used at 2 μM label concentration. A quantity of 500 nM of the
respective DUB was added to start the assay and reaction progression was followed
by measuring FP signal at Excitation: 540 nm, Emission: 590/590 nm. A reaction
without DUB was run in parallel to subtract baseline drift from the experimental
data. An exponential function FP ¼ FP0  FPminð Þ ´ ekobs ´ t þ FPmin; where FP0—
FP is the signal of ubiquitinated substrate and FPmin—FP the signal of free TAM-
RAUb, was ﬁtted to determine kobs(NCP) as a measure of the enzymes processivity.
To normalize the data to the intrinsic DUB activity on minimal substrate cleavage
of 2 μM UbRho was measured under the same conditions. The curve was ﬁtted to
obtain kobs(Rho). kobs(NCP) was then normalized to kobs(Rho) using the equation
kobs normð Þ
kobs NCPð Þ ERho½ 
kobs Rhoð Þ ENCP½  ; where [ERho] is the concentration of the DUB in the reaction
with minimal substrate and [ENCP] is the concentration of the DUB in the reaction
with NCP.
Biotinylation and USP48 inactivation and SPR measurements. Measurements
were done on a Biacore T200 (GE). NCPs of different ubiquitination status at a
concentration of 2 μM were biotinylated over night at 4 °C using EZ-link Sulfo-
NHS-LC-Biotin (Thermo Fisher) with a 2:1 excess of NCP over biotin. Biotiny-
lation was stopped by adding 1 mM TRIS pH 7.5. USP48 at 30 μM was inactivated
by incubating with 25 mM Iodoacetamide for 20 min at room temperature. Excess
Iodoacetamide was removed using Zeba Spin Desalting Columns (Thermo Fisher)
according to manufacturer’s protocol. The buffer used for SPR experiments was 25
mM HEPES pH 7.5, 150 mM NaCl, 0.05% TWEEN-20, 1 mgml−1 bovine serum
albumin (BSA), 1 mg ml−1 Dextran. Biotinylated NCPs were immobilized on an SA
chip (Series S SA chip, GE) to roughly 100 RU and inactivated USP48 was ﬂown
over at varying concentrations with two-fold dilutions starting at 2.56 μM. A
reference ﬂow cell without immobilized NCP was included to subtract unspeciﬁc
binding. Data were processed using GraphPad Prism 7.0.
NCP cleavage reactions with USP48. All cleavage reactions were done in reac-
tion buffer 25 mM HEPES pH 7.5, 150 mM NaCl, 5 mM DTT. NCPs ubiquitinated
on either one of the H2A ubiquitination sites with TAMRAUb were used and
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reaction was started by addition of USP48. Concentrations are indicated in the
ﬁgures. Samples were taken at the indicated time points and reaction was stopped
by addition of SDS-loading dye. Samples were separated on a NuPage 4–12 % Bis-
TRIS SDS gel in MES buffer (Thermo Fisher) and the ﬂuorescence signal was read
out on a Typhoon FLA-9500 gel scanner (GE Healthcare). Quantiﬁcation of
individual bands was achieved by measuring the ﬂuorescence intensity and relating
it to the total intensity of each lane at a known concentration of dye used in the
respective assay. This way each band represents a fraction of the concentration of
dye used in the experiment. To convert to molar concentration of ubiquitinated
histones the dye concentration was divided by the number of labeled ubiquitins
present on the respective histone species (H2Aub3, H2Aub2, and H2Aub1).
USP48 kinetic modeling. USP48 cleavage reactions as described above were done
at varying substrate and enzyme concentration to allow subsequent kinetic mod-
eling. The different conditions are indicated in Supplementary Figs. 3–4. The
concentrations of the different reaction species were quantiﬁed according to the
ﬂuorescence signal to yield molar concentrations of the ﬂuorophore. The molar
concentration of ﬂuorophore was then dividied by the number of ﬂuorophores
present on each individual reaction species (three for H2Aub3, two for H2Aub2
and 1 for H2Aub and ub) to determine the molar amounts of each species. The
quantiﬁed data were used to globally ﬁt the three different catalytic rates deﬁned in
Fig. 2e, kcat(ub3), kcat(ub2), and kcat(ub1). The association constant was ﬁxed to kon =
20 μM−1 s−1, an order of magnitude we routinely observe in SPR experiments. koff
was determined by an initial round of ﬁtting where it was allowed to vary between
2 and 20 s−1 to reﬂect the range of the experimentally determined Kd between 100
nM as approximated by SPR and 1 μM as estimated by gel shift assays. The model
consistently chose 20 s−1 as the best ﬁt value and koff was ﬁxed to this value in
subsequent ﬁtting steps. All ﬁtting was done using the software KinTek Explorer
Version 6.3.170707. The amount of different conditions needed for a reliable ﬁt of
the variables has been determined in an iterative fashion by adding more condi-
tions and subsequently analyze the goodness of ﬁt (as described in statistics, see
below). With the number of conditions used now χ2 values fall into a well-deﬁned
minimum, suggesting that the ﬁtted parameters are well restrained by the
experimental data.
DNA repair reporter assays. U20S-DR3-GFP (GC), U20S-SA-GFP (SSA), and
U20S-EJ5-GFP (NHEJ) were a generous gift from Jeremy Stark (City of Hope,
Duarte USA). U20S reporter cell lines were simultaneously co-transfected with
siRNA using Dharmafect1 (Dharmacon) and DNA (RFP, or Flag-USP48 and I-
Sce1 endonuclease expression constructs) using FuGene6 (Promega) respectively.
After 16 h the media was replaced and cells were grown for a further 48 h before
ﬁxation in 2% paraformaldehyde (PFA). RFP and GFP double positive cells were
scored by FACS analysis using a CyAn ﬂow cytometer and a minimum of 10,000
cells counted. Data were analyzed using Summit 4.3 software. Each individual
experiment contained three technical repeats and normalized to siRNA controls or
to WT-complemented cells. Graphs shown are combined data from a minimum of
three independent experiments and error bars show SE.
Colony assays. Cells were plated at 2 × 105 cells per ml in a 24-well plate and
treated as indicated in the ﬁgure legends. Cells were then trypsinized and plated at
limiting dilution to form colonies and grown on for 10–14 days. Colonies were
stained using 0.5% crystal violet (BDH Chemicals) in 50% methanol and counted.
Each individual experiment contained three technical repeats and is normalized to
untreated controls. Graphs shown are combined data from a minimum of three
independent experiments and error bars show SE.
Laser micro-irradiation. Laser micro-IR experiments were performed on BrdU-
presensitized cells (10 μM BrdU, 24 h) as described64 using a Zeiss PALM
MicroBeam equipped with a 355 nm UV-A pulsed-laser and the × 40 objective with
laser output at 40%, assisted by the PALMRobo-Software supplied by the manu-
facturer. Cells were ﬁxed after 30 min in 4 % PFA before staining by
immunoﬂuorescence.
Measurement of resection tracks (BrdU). Twenty-four hours before ﬁxation
cells were incubated with 10 µM BrdU and then 10 µM Olaparib for the last 16 h of
treatment. Cells were trypsinized and resuspended in ice-cold phosphate-buffered
saline (PBS) to a concentration of 10 × 105 cells per ml. In order to lyse the cells, 2
µl of sample was placed on a slide and mixed with 7 µl of spreading buffer (200 mM
Tris pH 7.4, 50 mM EDTA, 0.5% SDS) and incubated for 2 min. Slides were then
placed at a shallow angle to cause the droplet to gradually run down the slide,
ensuring constant movement of the droplet. Slides were ﬁxed in 3 : 1 Methanol:
Acetic Acid for 10 min and then stored at 4 °C. Slides were washed in PBS and
Blocking solution (2 g BSA, 200 µl Tween-20, 200 ml PBS) and then incubated with
mouse anti BrdU primary antibody. Slides were washed in PBS before being
incubated with AlexaFluor donkey anti mouse 488. Images were taken on the Leica
DM6000B microscope and analysis performed using ImageJ software. Lengths were
calculated using a scale bar to convert pixels to µm and this ratio, of 3.493 pixels
per µm, was used to measure BrdU track lengths. Fibres (> 100) per treatment were
measured and plotted on a Whisker plot using Graphpad.
Immunoﬂuorescence. HeLa FlpIn, HeLa-Flag-USP48Iso2, HeLa-Flag-USP48-
C98SIso2, or HeLa-EGFP-USP48Iso1 cells were seeded onto coverslips and trans-
fected with siRNA, expression constructs and/ or induced with doxcycline as
described. Cells were labeled with 10 µM EdU 10min before IR using a Gamma-
cell 1000 Elite irradiator (caesium-137 source). At 2 h post IR, cells were washed
brieﬂy in CSK buffer (100 mM sodium chloride, 300 mM sucrose, 3 mM magne-
sium chloride, 10 mM PIPES pH 6.8) before ﬁxation with 4% PFA for 10 min. For
immunoﬂuorescence staining, cells were permeabilized with 0.2% Triton X-100 in
PBS for 10 min before blocking in 10 % fetal bovine serum in PBS. EdU was
visualized by Click-iT chemistry according to the manufacturer’s protocols (Life
Technologies) with Alexa-647-azide. Cells were incubated with primary antibody
for 1 h, washed three times in PBS, and incubated with secondary AlexaFluor
antibodies for 1 h. The DNA was stained using Hoechst at 1 : 20,000.
Microscopy. For 53BP1/BRCA1 foci spread analysis: Images of immuno-
ﬂuorescent staining were captured on the Zeiss 510 Meta confocal microscope,
using three lasers to give excitation at 647, 555, and 488 nM wavelengths. Images at
each wavelength were collected sequentially at a resolution of approximately
1,024 × 1,024 pixels, using the Plan-Apochromat × 100/1.4 Oil objective. All other
immunoﬂuorescent staining was imaged using the Leica DM6000B microscope
using a HBO lamp with 100W mercury short arc UV bulb light source and four
ﬁlter cubes, A4, L5, N3, and Y5, to produce excitations at wavelengths 360, 488,
555, and 647 nm, respectively. Images were captured at each wavelength sequen-
tially using the Plan Apochromat HCX × 100/1.4 Oil objective at a resolution of
1,392 × 1,040 pixels.
Statistics. BrdU resection tracks that were analysed by one-sided Mann–Whitney
test with center values given as median. All other statistical analysis was by two-
sided Student's T-test throughout. * p< 0.05, **p< 0.01, and ***P< 0.005. All
centre values are given as the mean and all error bars are SEM. For kinetic
modeling, data were ﬁtted globally to the deﬁned model by numerical integration
and best-ﬁt parameters were determined by ﬁnding minimum χ2 values using
KinTek Explorer. The quality of the ﬁt was evaluated by calculating the FitSpace
shown in Fig. 2e.
Data availability. The data sets generated during the current study are available
from the corresponding authors on reasonable request.
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